Displaying 1 - 1 of 1
| Active Ingredient | DABIGATRAN |
| Therapeutic Class | DIRECT THROMBIN INHIBITORS |
| Indications | Dabigatran is a direct thrombin inhibitor. It is used for the prophylaxis of venous thromboembolism in patients undergoing orthopaedic surgery and the prevention of stroke and systemic embolisation in More ... |
| Caution | Dabigatran should not be used in patients who are at a high risk for bleeding. It is contraindicated for those patients who have mechanical prosthetic heart valves because of thromboembolism and major More ... |
| Dose Range | Prophylaxis of venous embolism after orthropaedic surgery: Adult: 18-74 years, 110mg to be taken 1-4 hours after surgery, followed by 220mg once daily for 9 days , to be taken 12-24 hours after initial dose. Adult: 75years and older 110mg to be taken afte |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |